DR. JAMES E MANNING, MD
Medical Practice at Manning Dr, Chapel Hill, NC
License number
North Carolina 38128
Category
Medical Practice
Type
Neuromusculoskeletal Medicine, Sports Medicine
Address
Address
101 Manning Dr, Chapel Hill, NC 27599
Phone
(919) 966-4131
Professional information
James E Manning, Chapel Hill NC
Specialties:
Emergency Medicine Physician
Address:
101 Manning Dr, Chapel Hill, NC 27514
Board certifications:
American Board of Emergency Medicine Certification in Emergency Medicine
Dr. James E Manning, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Emergency Medicine
Address:
University North Carolina EMR
101 Manning Dr, Chapel Hill 27514
(919) 966-4131 (Phone)
101 Manning Dr, Chapel Hill 27514
(919) 966-4131 (Phone)
Certifications:
Emergency Medicine, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University North Carolina EMR
101 Manning Dr, Chapel Hill 27514
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
101 Manning Dr, Chapel Hill 27514
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Education:
Medical School
University of North Carolina At Chapel Hill
Graduated: 1985
University of North Carolina At Chapel Hill
Graduated: 1985
Selective Aortic Arch Perfusion Using Perfluorochemical And Alpha Adrenergic Agonist To Treat Cardiac Arrest
US Patent:
5216032, Jun 1, 1993
Filed:
Sep 30, 1991
Appl. No.:
7/769132
Inventors:
James E. Manning - Chapel Hill NC
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
A01N 3114, A01N 3318, A01N 2500
US Classification:
514718
Abstract:
A method of treating a subject in cardiac arrest, comprises blocking the descending aorta of the subject and then perfusing the aortic arch of the subject with a protective solution. The protective solution is one capable of delivering oxygen to the heart of said subject, such as a perfluorochemical blood substitute. Following perfusion, spontaneous circulation is restored.
In an improved embodiment of the foregoing, a vasoconstrictor such as epinephrine is administered concurrently with the perfusing step in an amount effective to enhance coronary perfusion with said protective solution.
Method Of Treating Cardiac Arrest And Apparatus For Same
US Patent:
5716318, Feb 10, 1998
Filed:
Apr 14, 1995
Appl. No.:
8/422338
Inventors:
James E. Manning - Chapel Hill NC
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
A61N 1362
US Classification:
600 16
Abstract:
A method of treating a subject in cardiac arrest comprises the steps of blocking the descending aorta of the subject and perfusing the aortic arch of the subject with a protective solution in an amount effective to deliver oxygen to the heart of the subject. The perfusing step is performed so that the protective solution infuses the aorta in a pulsatile rhythm. An apparatus for carrying out this method includes a storage unit for storing a protective solution, delivery apparatus for delivering the protective solution to the aorta of the subject, wherein the delivery apparatus is fluidly connected with said storage means, and a pulsing device connected with the delivery means. The pulsing device induces the protective solution to be delivered to the aorta in a pulsatile rhythm.
Method Of Treating Cardiac Arrest
US Patent:
5678570, Oct 21, 1997
Filed:
Apr 14, 1995
Appl. No.:
8/422337
Inventors:
James E. Manning - Chapel Hill NC
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
A61B 1900
US Classification:
128897
Abstract:
A method of treating a subject under cardiac arrest comprises the steps of: blocking the descending aorta of the subject; then withdrawing blood from the subject; oxygenating the blood withdrawn from the subject; and perfusing the aortic arch of the subject with oxygenated blood in an amount effective to deliver oxygen to the heart of the subject. This method enables the subject to continue to receive oxygenating material (i. e. , blood in this instance) without the danger of volume overload that would be present if another oxygenated solution were continuously infused.
Selective Aortic Arch Perfusion
US Patent:
5437633, Aug 1, 1995
Filed:
Mar 30, 1994
Appl. No.:
8/211374
Inventors:
James E. Manning - Chapel Hill NC
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
A61M 3100
US Classification:
604 53
Abstract:
A method of treating a subject in cardiac arrest, comprises blocking the descending aorta of the subject and then perfusing the aortic arch of the subject with a protective solution. The protective solution is one capable of delivering oxygen to the heart of said subject, such-as a perfluorochemical blood substitute. Following perfusion, spontaneous circulation is restored.
In an improved embodiment of the foregoing, a vasoconstrictor such as epinephrine is administered concurrently with the perfusing step in an amount effective to enhance coronary perfusion with said protective solution.